Will the Government of India respond to the Gambian Parliament’s claim that 66 children died from Indian medicines?


Video: In October last, the World Health Organization had cited the medicines of Medan Pharmaceuticals Company of Haryana as the possible cause of death of 66 children in the African country Gambia. Now the parliamentary committee of Gambia has confirmed this claim in its report. Banjot Kaur of The Wire is telling in detail on the matter.

new Delhi: The World Health Organization (WHO) issued an alert in October stating that four syrups manufactured by Haryana-based Maiden Pharmaceuticals were potentially linked to the death of around seventy children in an African country – The Gambia.

The WHO said that two toxins – diethylene glycol (DEG) and ethylene glycol – were found in ‘unacceptable levels’ in these drugs. Then the Drug Controller of India started the investigation. In December, he gave a clean chit to the company and said that no poisonous substance was found in these medicines.

Although, the Thealike Co Swiss Lab’s a report Has been received, where WHO had sent samples for examination in October. The report states that DEGs were found between 1-21% in all the four products. The history of DEG poisoning, which resulted in the death of many children, was enough to tell that the presence of DEG in this amount was much more than enough to cause death.

In October, a committee of the Parliament of Gambia was formed whose task was to get to the bottom of these deaths. That committee submitted its report to the Parliament on 20 December. in that report the Thealike The previously reported findings have been confirmed by. The report of the committee held Medan Pharma guilty and accountable for the deaths of the children.

The committee said that the company did not follow the rules related to good manufacturing practices and DEG present in its products was responsible for the death of the children. This parliamentary committee of Gambia also demanded a case against the company. But any response is yet to be given by the Government of India on this demand of Gambia.

(To read the report of the parliamentary committee click here,

Categories: World, India, Video

Tagged as: CDSCO, Central Drug Laboratory, Centre, FDA, Gambia, Gambian Parliament, Kofexmalin Baby Cough Syrup, Magrip N Cold Syrup, Maiden Pharmaceuticals Limited, Makoff Baby Cough Syrup, News, Promethazine Oral Solution, The Wire Video, WHO, World Health Organization


Source link

Comments are closed.